- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
2019
CNS Neurol Disord Drug Targets
18
6
Although much prescribed, the class of neurotrophic/antinociceptive nutraceuticals, is generally supported by relatively few controlled trials. Looking into the existent literature, we came across an old registration study about micronized palmitoylethanolamide (PEA) in patients with low back pain – sciatica.